Arkolith/Insider Trading/CNST/Form 4

Audia James E

DirectorCONSTELLATION PHARMACEUTICALS INC (CNST) · full profile →Form 4 · filed Jul 19, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2021Disposed to issuer(D)25K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2021Disposed to issuer(D)13K——0
Jul 15, 2021Disposed to issuer(D)8K——0
Jul 15, 2021Disposed to issuer(D)13K——0
Jul 15, 2021Disposed to issuer(D)1K——0
Jul 15, 2021Disposed to issuer(D)13K——0
Jul 15, 2021Disposed to issuer(D)25K——0
Jul 15, 2021Disposed to issuer(D)2K——0
Jul 15, 2021Disposed to issuer(D)9K——0
Jul 15, 2021Disposed to issuer(D)12K——0
Jul 15, 2021Disposed to issuer(D)9K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-21-004979) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML